Search PubMedSearch

Biomedical subjects

C Biddle

Publications and source records attributed to C Biddle.

14 recordsLinked to original sources

Transdermal and transmucosal administration of pain-relieving and anxiolytic drugs: a primer for the critical care practitioner.

Recent developments in both applied dermal physiology and in pharmaceutical technology are paving the way towards the introduction of novel routes of drug administration which will have both a direct and an indirect effect on critical care practice. Among these approaches, transdermal and transmucosal applications appear particularly promising because of the accessibility, noninvasiveness, compliance, safety, and efficacy associated with the techniques. Fentanyl, as the prototypical opioid for transdermal and transmucosal applications, and midazolam (a benzodiazepine) will ultimately be replaced with newer synthetic compounds specifically formulated for these routes of administration.

Administration, Buccal

AANA Journal course: update for nurse anesthetists--monitoring the brain for hypoxic events.

Monitoring of brain oxygen content is highly desirable as this organ is highly intolerant to hypoxia from a variety of possible etiologies, many of which can occur during the administration of anesthesia. Most of the modalities directed at brain oxygen monitoring are highly technical and currently are in various stages of evolution worldwide. These approaches include those which access brain oxygen content by both direct and indirect means. This lesson reviews the major areas of research currently underway and suggests that we should be optimistic that this technology may be available to us clinically in the foreseeable future.

Cerebrovascular Circulation

The morbidity and mortality conference: a prolegomenon on its role as an anesthesia risk-management tool.

Although the morbidity and mortality conference (MMC) is an essential component of any anesthesia risk-management program, it has not undergone systematic analysis. All MMC narratives detailing the proceedings at two university centers from June 1988 to June 1990 were examined by content analysis and the unique perspectives of MMC participants were captured. The majority of MMC events were of an educational or informational nature; 32% dealt with patient complications, and 14% involved incidents that could have led to detrimental outcomes. Participant beliefs were ultimately organized into categories describing "the lived experience" of the MMC. These included (1) disclosure of knowledge, (2) correspondence of relationship, (3) teaching conformity to rule, (4) developing a sense of aplomb, (5) preparation for litigation, (6) the ceremony, (7) a quality-assurance mechanism, (8) a personal lambaste function, and (9) an instrument of punitive retribution. The MMC appeared improperly named; "case conference" or "clinical teaching conference" may serve as a more accurate rubric. The MMC played a variety of cognitive and affective roles. Recognition of the nature of the teaching and learning associated with the MMC will allow risk managers to utilize it optimally in achieving envisioned objectives that enhance patient outcomes.

Anesthesiology

AANA Journal course: new technologies in anesthesia: update for nurse anesthetists--a look to the future--transdermal and transmucosal administration of anesthetic drugs.

Recent developments in both applied dermal physiology and in pharmaceutical technology are paving the way toward the introduction of novel routes of drug administration into anesthetic practice. Among these approaches, transdermal and transmucosal applications have shown particular promise in clinical trials all over the world. The emergence of new drug administration techniques that help to improve drug compliance, enhance safety and diminish both physical and psychological trauma will prove to be desirable additions to the anesthetist's armamentarium. This installment of the AANA Journal course will explore the latest developments in these areas destined to have a significant impact on the nurse anesthetist's clinical practice.

Administration, Buccal

The clinical nurse anesthetist as diagnostic sleuth.

Two cases are presented where observations made during anesthetic management led to appropriate diagnoses that otherwise might not have occurred in a timely fashion. In the first case, an early diagnosis of myasthenia gravis was facilitated; while in the second case, an improbable response led to rethinking of the initial diagnosis. The role of the nurse anesthetist in being alert to the consequences of unusual clinical and theoretical responses on behalf of the patient is depicted.

Adult

The nature of sleep.

Normal human sleep is often described as a state of reduced activity and reactivity, a kind of low general vigilance. Despite decades of intense scrutiny, our understanding of natural sleep is still incomplete. The two fundamental stages of sleep, nonrapid eye movement (NREM) and rapid eye movement (REM), are present in man as well as animals. Problems with sleep are frequent complaints of modern man, and a variety of these complaints are explored. Cognizance of the essence of normal human sleep may facilitate the anesthetist's understanding of pharmacologically induced sleep.

Anesthesia

The efficacy of sighs in patients with COPD undergoing general anesthesia and controlled ventilation.

Fourteen patients with COPD underwent elective procedures below the umbilicus, all receiving a standard anesthetic. They were randomized to one of four groups differentiated by the presence or absence of sighing during mechanical ventilation. Patients who were sighed experienced both statistically and clinically significant improvement in their oxygenation efficiency as measured by the alveolar to arterial oxygen gradient.

Aged

Stimulation of transplanted 3-methylcholanthrene-induced sarcomas in mice by specific immune ahd by normal serum.

Serum from Bl x C3H mice carrying syngeneic, progressively growing, highly immunogenic 3-methylcholanthrene-induced tumors when admixed with the specific tumor and inoculated into immunologically crippled syngeneic recipients, stimulated growth as compared with serum from control normal mice. It appears that this acceleration of tumor growth is an immune effect since it is not present when a non-immunogenic (spontaneous tissue culture) tumor is used; and the active factor can be absorbed from the serum by the specific tumor but not by an immunologically unrelated tumor. Normal serum per se also stimulated tumor growth, but to a smaller extent.

Animals